*In vitro effectiveness does not predict clinical performance.
1 Data on file. Covalon Technologies Ltd.
Covalon Technologies Ltd. (2011, March – April) A Human Repeat Patch Test Study.
Identifier: NCT01368146 https://clinicaltrials.gov/ct2/show/NCT01368146
3 Oehlke S, Steger M. Management of CHG-Associated Dermatitis at Central Line Sites in Pediatric Patients. Clinical Abstracts From the WOCN® Society's 46th Annual Conference Nashville, Tennessee June 21-25, 2014.
4 Hedgepath N, Messina V, Kalowes P. Clinical performance of a new clear silicone adhesive dressing with chlorhexidine and silver for central vascular access devices (VADs): Wearability, Comfort, Incidence of Irritant Contact Dermatitis. Poster Publication: SAWC Fall, Las Vegas, USA, 2014